Trends in Glycoscience and Glycotechnology
Online ISSN : 1883-2113
Print ISSN : 0915-7352
ISSN-L : 0915-7352
Glycosylation of α1-Acid Glycoprotein (Orosomucoid) in Health and Disease
Occurrence, Regulation and Possible Funtional Implications
Willem Van DijkEls C.M. Brinkman-Van der LindenEllen C. Havenaar[in Japanese]
Author information
JOURNAL FREE ACCESS

1998 Volume 10 Issue 53 Pages 235-245

Details
Abstract

α1-Acid glycoprotein (AGP) is an acute-phase glycoprotein with five N-linked glycans, exhibiting substantial heterogeneity in their structures. This heterogeneity results from the presence in plasma of various distinct AGP glycoforms of which the plasma levels, and thus the relative occurrence of these glycoforms, are strictly dependent on the pathophysiological condition determined by cytokines and hormones. These humoral factors induce changes in the glycosylation process of the parenchymal liver cells, which are independent of the rate of synthesis of the AGP aglycon. Results are reviewed regarding the characterization and regulation of the changes in glycosylation of AGP under various physiological and pathological states, as well as the possible anti-inflammatory effects of different AGP glycoforms.

Content from these authors
© FCCA, Forum; Carbohydrates Coming of Age
Next article
feedback
Top